BPC 157 remains one of the most widely recognised peptides associated with tissue repair signalling, connective tissue recovery research, and gastrointestinal protection studies
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Targeted Benefit: While deficiency is rare, supplementation is highly effective for individuals experiencing thinning due to low biotin levels
Given these favorable properties, further investigation into the mechanisms through which tripeptides interact with skin cells and the ECM may uncover new strategies for improving tissue repair [24, 32-36]
For more important safety and laboratory/test information, please click here
Combining it with another GLP-1 or GIP agonist (semaglutide, tirzepatide) would compound the same receptor load and the same GI and hypoglycemia risks with no efficacy evidence to support it